Cargando…

The evaluation of levosimendan in patients with acute myocardial infarction related ventricular septal rupture undergoing cardiac surgery: a prospective observational cohort study with propensity score analysis

STUDY OBJECTIVE: The purpose of the present study was to evaluate the efficacy of levosimendan in patients with acute myocardial infarction related ventricular septal rupture (AMI-VSR) underwent cardiac surgery. DESIGN: Prospective observational cohort study with propensity score analysis. PATIENTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ze-Shi, Wang, Kuo, Pan, Tuo, Sun, Yan-Hua, Liu, Chang, Cheng, Yong-Qing, Zhang, He, Zhang, Hai-Tao, Wang, Dong-Jin, Chen, Zu-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063086/
https://www.ncbi.nlm.nih.gov/pubmed/35501683
http://dx.doi.org/10.1186/s12871-022-01663-z
_version_ 1784699092442546176
author Li, Ze-Shi
Wang, Kuo
Pan, Tuo
Sun, Yan-Hua
Liu, Chang
Cheng, Yong-Qing
Zhang, He
Zhang, Hai-Tao
Wang, Dong-Jin
Chen, Zu-Jun
author_facet Li, Ze-Shi
Wang, Kuo
Pan, Tuo
Sun, Yan-Hua
Liu, Chang
Cheng, Yong-Qing
Zhang, He
Zhang, Hai-Tao
Wang, Dong-Jin
Chen, Zu-Jun
author_sort Li, Ze-Shi
collection PubMed
description STUDY OBJECTIVE: The purpose of the present study was to evaluate the efficacy of levosimendan in patients with acute myocardial infarction related ventricular septal rupture (AMI-VSR) underwent cardiac surgery. DESIGN: Prospective observational cohort study with propensity score analysis. PATIENTS: There were 261 patients with AMI-VSR in our study. After 1:1 propensity matching, 106 patients (53 levosimendan and 53 control) were selected in the matched cohort. INTERVENTIONS: None. MEASUREMENTS: Patients who received levosimendan were assigned to the levosimendan group (n = 164). The patients who were not received were levosimendan assigned to the control group (n = 97). The levosimendan was initiated immediately after cardiopulmonary bypass. Then, it has been maintained during the postoperative 3 days. The poor outcomes were identified as follows: death and postoperative complications (postoperative stroke, low cardiac output syndromeneeded mechanical circulatory support after surgery, acute kidney injury (≥ stage III), postoperative infection or septic shock, new developed atrial fibrillation or ventricular arrhythmias). MAIN RESULTS: Before matching, the control group had more length of ICU stay (6.69 ± 3.90 d vs. 5.20 ± 2.24 d, p < 0.001) and longer mechanical ventilation time (23 h, IQR: 16–53 h vs. 16 h, IQR: 11–23 h, p < 0.001). Other postoperative outcomes have not shown significant differences between two groups. After matching, no significant difference was found between both groups for all postoperative outcomes. The Kaplan–Meier survivul estimate and log-rank test showed that the 90-day survival had no significant differences between two groups before and after matching. CONCLUSION: Our study found that a low-dose infusion of levosimendan in AMI-VSR patients underwent surgical repair did not associated with positively affect to postoperative outcomes.
format Online
Article
Text
id pubmed-9063086
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90630862022-05-04 The evaluation of levosimendan in patients with acute myocardial infarction related ventricular septal rupture undergoing cardiac surgery: a prospective observational cohort study with propensity score analysis Li, Ze-Shi Wang, Kuo Pan, Tuo Sun, Yan-Hua Liu, Chang Cheng, Yong-Qing Zhang, He Zhang, Hai-Tao Wang, Dong-Jin Chen, Zu-Jun BMC Anesthesiol Research STUDY OBJECTIVE: The purpose of the present study was to evaluate the efficacy of levosimendan in patients with acute myocardial infarction related ventricular septal rupture (AMI-VSR) underwent cardiac surgery. DESIGN: Prospective observational cohort study with propensity score analysis. PATIENTS: There were 261 patients with AMI-VSR in our study. After 1:1 propensity matching, 106 patients (53 levosimendan and 53 control) were selected in the matched cohort. INTERVENTIONS: None. MEASUREMENTS: Patients who received levosimendan were assigned to the levosimendan group (n = 164). The patients who were not received were levosimendan assigned to the control group (n = 97). The levosimendan was initiated immediately after cardiopulmonary bypass. Then, it has been maintained during the postoperative 3 days. The poor outcomes were identified as follows: death and postoperative complications (postoperative stroke, low cardiac output syndromeneeded mechanical circulatory support after surgery, acute kidney injury (≥ stage III), postoperative infection or septic shock, new developed atrial fibrillation or ventricular arrhythmias). MAIN RESULTS: Before matching, the control group had more length of ICU stay (6.69 ± 3.90 d vs. 5.20 ± 2.24 d, p < 0.001) and longer mechanical ventilation time (23 h, IQR: 16–53 h vs. 16 h, IQR: 11–23 h, p < 0.001). Other postoperative outcomes have not shown significant differences between two groups. After matching, no significant difference was found between both groups for all postoperative outcomes. The Kaplan–Meier survivul estimate and log-rank test showed that the 90-day survival had no significant differences between two groups before and after matching. CONCLUSION: Our study found that a low-dose infusion of levosimendan in AMI-VSR patients underwent surgical repair did not associated with positively affect to postoperative outcomes. BioMed Central 2022-05-03 /pmc/articles/PMC9063086/ /pubmed/35501683 http://dx.doi.org/10.1186/s12871-022-01663-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Ze-Shi
Wang, Kuo
Pan, Tuo
Sun, Yan-Hua
Liu, Chang
Cheng, Yong-Qing
Zhang, He
Zhang, Hai-Tao
Wang, Dong-Jin
Chen, Zu-Jun
The evaluation of levosimendan in patients with acute myocardial infarction related ventricular septal rupture undergoing cardiac surgery: a prospective observational cohort study with propensity score analysis
title The evaluation of levosimendan in patients with acute myocardial infarction related ventricular septal rupture undergoing cardiac surgery: a prospective observational cohort study with propensity score analysis
title_full The evaluation of levosimendan in patients with acute myocardial infarction related ventricular septal rupture undergoing cardiac surgery: a prospective observational cohort study with propensity score analysis
title_fullStr The evaluation of levosimendan in patients with acute myocardial infarction related ventricular septal rupture undergoing cardiac surgery: a prospective observational cohort study with propensity score analysis
title_full_unstemmed The evaluation of levosimendan in patients with acute myocardial infarction related ventricular septal rupture undergoing cardiac surgery: a prospective observational cohort study with propensity score analysis
title_short The evaluation of levosimendan in patients with acute myocardial infarction related ventricular septal rupture undergoing cardiac surgery: a prospective observational cohort study with propensity score analysis
title_sort evaluation of levosimendan in patients with acute myocardial infarction related ventricular septal rupture undergoing cardiac surgery: a prospective observational cohort study with propensity score analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063086/
https://www.ncbi.nlm.nih.gov/pubmed/35501683
http://dx.doi.org/10.1186/s12871-022-01663-z
work_keys_str_mv AT lizeshi theevaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis
AT wangkuo theevaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis
AT pantuo theevaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis
AT sunyanhua theevaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis
AT liuchang theevaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis
AT chengyongqing theevaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis
AT zhanghe theevaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis
AT zhanghaitao theevaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis
AT wangdongjin theevaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis
AT chenzujun theevaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis
AT lizeshi evaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis
AT wangkuo evaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis
AT pantuo evaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis
AT sunyanhua evaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis
AT liuchang evaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis
AT chengyongqing evaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis
AT zhanghe evaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis
AT zhanghaitao evaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis
AT wangdongjin evaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis
AT chenzujun evaluationoflevosimendaninpatientswithacutemyocardialinfarctionrelatedventricularseptalruptureundergoingcardiacsurgeryaprospectiveobservationalcohortstudywithpropensityscoreanalysis